The Future of the U.S. Biosimilars Market: Development, Education, and Utilization

Join Friends of Cancer Research and the Duke-Margolis Center for Health Policy for a half-day forum bringing together clinicians, originator and biosimilar drug sponsors, advocates, regulators, and payers to tackle remaining uncertainty surrounding the future of the US biosimilars market.